Next-Generation Sequencing Is Revolutionizing Precision Medicine
Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.
Read More
Search Results for: lung cancer
How Single-Cancer Testing Could Revolutionize Diagnostics
Veracyte CEO Marc Stapley outlines how single-cancer testing is giving pathologists, clinicians, and patients an edge.
Read More
New Diagnostic Method Improves Pediatric Infection Detection
Researchers have recommended a method to help diagnose preschool age children with primary ciliary dyskinesia (PCD).
Read More
Median Technologies Completes FDA Q-Submission Phase for Lung Cancer Screening Software
The Q-submission phase is a regulatory step which allows regular and in-depth discussions with the FDA on key topics.
Read More
Lucence Announces Medicare Reimbursement Decision for Lung Cancer Assay
Lucence announced that Palmetto GBA finalized a foundational local coverage determination (LCD) for the LiquidHALLMARKassay.
Read More